Literature DB >> 29733842

Barriers to insurance coverage for transgender patients.

Claire Learmonth1, Rebekah Viloria2, Cei Lambert3, Hilary Goldhammer4, Alex S Keuroghlian5.   

Abstract

Transgender people report discrimination in access to health care that is associated with numerous poor health outcomes, including higher prevalence of HIV infection, substance use disorders, and suicide attempts. The field of obstetrics and gynecology is uniquely positioned to meet a wide range of health care needs for transgender people, and obstetrician-gynecologists can and ought to provide gender-affirming care for these patients. Despite growing evidence that gender-affirming care is both necessary and cost-effective, transgender patients continue to face barriers to securing insurance coverage, which prevents clinicians from practicing standards of care. The purpose of this article is to delineate the major barriers transgender patients face when seeking insurance reimbursement for services routinely available to cisgender (nontransgender) women.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  electronic health record; gender identity; gender queer; gender-affirming; insurance barriers; lesbian, gay, bisexual, and transgender; nonbinary; obstetrics and gynecology; third-party payer; transgender; transsexual

Mesh:

Substances:

Year:  2018        PMID: 29733842     DOI: 10.1016/j.ajog.2018.04.046

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

Review 1.  Breast augmentation in the transgender patient: narrative review of current techniques and complications.

Authors:  Jenna C Bekeny; Elizabeth G Zolper; Oscar J Manrique; Kenneth L Fan; Gabriel Del Corral
Journal:  Ann Transl Med       Date:  2021-04

2.  Insurance Coverage and Use of Hormones Among Transgender Respondents to a National Survey.

Authors:  Daphna Stroumsa; Halley P Crissman; Vanessa K Dalton; Giselle Kolenic; Caroline R Richardson
Journal:  Ann Fam Med       Date:  2020-11       Impact factor: 5.166

3.  Potential association between type 1 diabetes mellitus and gender dysphoria.

Authors:  Santhi N Logel; M Tracy Bekx; Jennifer L Rehm
Journal:  Pediatr Diabetes       Date:  2019-12-04       Impact factor: 4.866

4.  A Blueprint for Planning and Implementing a Transgender Health Program.

Authors:  Anna M Morenz; Hilary Goldhammer; Cei A Lambert; Ruben Hopwood; Alex S Keuroghlian
Journal:  Ann Fam Med       Date:  2020-01       Impact factor: 5.166

5.  National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer.

Authors:  Matthew B Schabath; Catherine A Blackburn; Megan E Sutter; Peter A Kanetsky; Susan T Vadaparampil; Vani N Simmons; Julian A Sanchez; Steven K Sutton; Gwendolyn P Quinn
Journal:  J Clin Oncol       Date:  2019-01-16       Impact factor: 44.544

6.  Transition Coverage and Clarity in Self-Insured Corporate Health Insurance Benefit Plans.

Authors:  Anna Kirkland; Shauhin Talesh; Angela K Perone
Journal:  Transgend Health       Date:  2021-07-30

7.  Transphobia, encoded: an examination of trans-specific terminology in SNOMED CT and ICD-10-CM.

Authors:  A Ram; Clair A Kronk; Jacob R Eleazer; Joseph L Goulet; Cynthia A Brandt; Karen H Wang
Journal:  J Am Med Inform Assoc       Date:  2022-01-12       Impact factor: 7.942

Review 8.  The Evolving Role of Pharmacists in Transgender Health Care.

Authors:  Jan S Redfern; Michael W Jann
Journal:  Transgend Health       Date:  2019-04-11

9.  Legislation, Market Size, and Access to Gender-affirming Genital Surgery in the United States.

Authors:  Alexander F Dagi; Elizabeth R Boskey; Laura C Nuzzi; Christine O Kang; Oren Ganor; Brian I Labow; Amir H Taghinia
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-02-16

Review 10.  A systematic review of decision aids for gender affirming therapy.

Authors:  Peter Scalia; Katherine M Tighe; Glyn Elwyn; Pamela J Bagley; Heather B Blunt; Benjamin Boh; Oakland C Walters; Rachel A Moses
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.